Quick Answer
Sonoma Pharmaceuticals, Inc. reported Gross Profit of $5.46 million for fiscal year 2025.
Sonoma Pharmaceuticals, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $5.46M | +15.2% |
| 2024 | $4.75M | +6.0% |
| 2023 | $4.48M | +12.1% |
| 2022 | $3.99M | -39.1% |
| 2021 | $6.56M | -19.2% |
| 2020 | $8.12M | -8.5% |
| 2019 | $8.88M | +21.5% |
| 2018 | $7.31M | +29.0% |
| 2017 | $5.67M | +114.0% |
| 2016 | $2.65M | -63.7% |
| 2015 | $7.29M | -13.2% |
| 2014 | $8.40M | -21.8% |
| 2013 | $10.74M | +23.3% |
| 2012 | $8.71M | +41.9% |
| 2011 | $6.14M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.65M | +29.9% | -22.2% |
| September 30, 2025 | $2.12M | +55.8% | +44.8% |
| June 30, 2025 | $1.46M | +12.1% | +15.3% |
| December 31, 2024 | $1.27M | -13.0% | -6.7% |
| September 30, 2024 | $1.36M | +37.5% | +4.2% |
| June 30, 2024 | $1.31M | +8.5% | -10.5% |
| December 31, 2023 | $1.46M | +75.7% | +47.5% |
| September 30, 2023 | $990.0K | -35.5% | -17.8% |
- Sonoma Pharmaceuticals, Inc. showed an increase of +15.2% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2025 period, Sonoma Pharmaceuticals, Inc.’s gross profit has declined by 11.0% (from $6.14 million to $5.46 million).
- The most recent figure is from Sonoma Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: